$39.86+0.71 (+1.81%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.
Hemab Therapeutics Holdings (COAG) Stock
Hemab Therapeutics Holdings (COAG) closed at $39.86 on Nov 19, 2026.
Sources Company filings, market prices and computed by Tenet Filings, prices and TenetHow we compute thisNot investment advice
Key stats
- Close
- $39.86
- Nov 19, 2026
Industry: Biological Products, Except Diagnostic Substances
Hemab Therapeutics Holdings Inc. isn't scored yet Not enough ingested fundamentals to compute a Tenet Score for this stock.
Tenet Score
Not scored. We do not hold normalized financials for this listing, so the Tenet value screens do not apply. That is usually a foreign-domiciled ADR or a very new listing. Its price, chart, and news below are its own.
Price
Loading chart…
P/E
—
no P/E on file
P/B
—
no P/B on file
P/S
—
no P/S on file
ROE
—
no ROE for this year
Operating margin
—
no operating margin on file
Net margin
—
no net margin on file
Current ratio
—
no current ratio on file
Net debt / EBITDA
—
no leverage ratio on file
EPS CAGR 5y
—
needs five years of positive earnings
Market cap
—
no market cap on file
Div yield
—
no yield on file
52-wk range
—
no 52-week range on file
The rest of this report
Which sections of this report have data for this listing, and a live peek at each.
About Hemab Therapeutics Holdings Inc.
We are a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. Our mission is to build the leading coagulation company by discovering, developing, and comm…
Not investment advice.




